Cancers, Free Full-Text

Emerging evidence suggests that a small subpopulation of cancer stem cells (CSCs) is responsible for initiation, progression, and metastasis cascade in tumors. CSCs share characteristics with normal stem cells, i.e., self-renewal and differentiation potential, suggesting that they can drive cancer progression. Consequently, targeting CSCs to prevent tumor growth or regrowth might offer a chance to lead the fight against cancer. CSCs create their niche, a specific area within tissue with a unique microenvironment that sustains their vital functions. Interactions between CSCs and their niches play a critical role in regulating CSCs’ self-renewal and tumorigenesis. Differences observed in the frequency of CSCs, due to the phenotypic plasticity of many cancer cells, remain a challenge in cancer therapeutics, since CSCs can modulate their transcriptional activities into a more stem-like state to protect themselves from destruction. This plasticity represents an essential step for future therapeutic approaches. Regarding self-renewal, CSCs are modulated by the same molecular pathways found in normal stem cells, such as Wnt/β-catenin signaling, Notch signaling, and Hedgehog signaling. Another key characteristic of CSCs is their resistance to standard chemotherapy and radiotherapy treatments, due to their capacity to rest in a quiescent state. This review will analyze the primary mechanisms involved in CSC tumorigenesis, with particular attention to the roles of CSCs in tumor progression in benign and malignant diseases; and will examine future perspectives on the identification of new markers to better control tumorigenesis, as well as dissecting the metastasis process.

PDF) Discovery and validation of methylation signatures in circulating cell- free DNA for early detection of esophageal cancer: a case-control study

Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

Cancers, Free Full-Text

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Radical causes of cancer

Cancers, Free Full-Text

Prostate Cancer.Csv - Colaboratory

Prostate Cancer: Symptoms, Causes & Treatment

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer